Korsana Biosciences, Inc. (KRSA)
30.86
+0.43
(+1.41%)
USD |
NASDAQ |
Nov 06, 15:16
Korsana Biosciences Net Income (TTM) : -6.707M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.707M |
| March 31, 2026 | -5.276M |
| December 31, 2025 | -3.528M |
| September 30, 2025 | -2.199M |
| June 30, 2025 | -1.946M |
| March 31, 2025 | -2.944M |
| December 31, 2024 | -3.057M |
| September 30, 2024 | -5.281M |
| June 30, 2024 | -10.47M |
| March 31, 2024 | -10.95M |
| December 31, 2023 | -12.59M |
| September 30, 2023 | -15.22M |
| June 30, 2023 | -13.72M |
| March 31, 2023 | -25.30M |
| December 31, 2022 | -35.10M |
| September 30, 2022 | -41.55M |
| June 30, 2022 | -48.43M |
| Date | Value |
|---|---|
| March 31, 2022 | -51.22M |
| December 31, 2021 | -51.65M |
| September 30, 2021 | -60.10M |
| June 30, 2021 | -67.62M |
| March 31, 2021 | -70.97M |
| December 31, 2020 | -77.80M |
| September 30, 2020 | -84.63M |
| June 30, 2020 | -93.13M |
| March 31, 2020 | -105.85M |
| December 31, 2019 | -123.01M |
| September 30, 2019 | -127.85M |
| June 30, 2019 | -129.82M |
| March 31, 2019 | -127.35M |
| December 31, 2018 | -115.25M |
| September 30, 2018 | -112.01M |
| June 30, 2018 | -107.91M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Q32 Bio, Inc. | 32.25M |
| IRulya Therapeutics, Inc. | -92.48M |
| Climb Bio, Inc. | -57.62M |
| PepGen Inc. | -71.94M |
| Bridgebio Oncology Therapeutics, Inc. | -182.11M |